PositoAI/ US/ Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc.

NasdaqCM: TENX · Healthcare

Positivity Index

#1,139 / 6,775

Global

#213 / 4,000

United States

Positivity Score

23,262

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

Tenax Therapeutics, Inc. — Overview & Financial Snapshot

Tenax Therapeutics, Inc. (NasdaqCM: TENX) is a Healthcare company, ranked #1,139 of 6,775 companies globally and #213 of 4,000 in United States on PositoAI, with a Positivity Score of 23,262. Its market capitalisation is ₹621.72 Cr ($65.87M), P/E ratio is -1.2 and P/B ratio is 0.58. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.

P/B Ratio 0.58

P/E Ratio -1.2

D/E Ratio 0.00

ROE -59.80%

Owes vs Owns ? 0.07× Low $0.07 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-139.70$-1.48

Forward EPS ₹-141.59$-1.50

Beta 0.92

Market Cap ₹621.72 Cr$65.87M

What these numbers mean →

What does Tenax Therapeutics, Inc. do?

What is Tenax Therapeutics, Inc.'s P/E and P/B ratio?

Tenax Therapeutics, Inc. has a P/E ratio of -1.2 and a P/B ratio of 0.58.

What is Tenax Therapeutics, Inc.'s debt-to-equity ratio?

Tenax Therapeutics, Inc. has a debt-to-equity ratio of 0.00.

How much does Tenax Therapeutics, Inc. owe compared with what it owns?

Tenax Therapeutics, Inc. owes $0.07 for every $1 it owns (balance sheet Jun 2026), which is low.

What is Tenax Therapeutics, Inc.'s Positivity rank?

Tenax Therapeutics, Inc. is ranked #1,139 of 6,775 companies globally and #213 of 4,000 in United States on PositoAI, with a Positivity Score of 23,262.

Does Tenax Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Tenax Therapeutics, Inc..

Where can I read the latest news about Tenax Therapeutics, Inc.?

Recent headlines about Tenax Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Tenax Therapeutics, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Tenax Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.